Hay fever drug to become prescription onlyBMJ 1997; 314 doi: http://dx.doi.org/10.1136/bmj.314.7090.1297d (Published 03 May 1997) Cite this as: BMJ 1997;314:1297
- Jacqui Wise
The hay fever treatment terfenadine is to become a prescription only medicine in Britain after concerns about its safety.
The Committee on Safety of Medicines said that when terfenadine is used as recommended it has a good safety record, but when it is taken by patients with heart or liver disease, in overdose, or with drugs which interact it can produce serious or even fatal cardiac arrhythmias. There have been 33 serious cardiac arrhythmias, including 14 deaths linked with taking the drug, most of them since the committee first issued warnings in 1992.
In the past couple of months …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial